Biotech Values

[Whalatane]

North. have you looked at PRTO . New high on increased vol today .
P 3 data due this month .
Wife is a PA in Renal. ( dialysis ) .
Her patients lose the ability to use their fistulas for dialysis on average in about 3 yrs ....after which a new one needs to be created , at a cost of roughly $16,000 in first yr ..creation -maturation -use.
She tells me that if PRTO's treatment can extend life of fistula use by at least 1 yr ...it will be very clinically significant .
Final P3 is a binary ...stock goes to 50c or less if it fails .
IF it succeeds she doesn't want to wait for the SUV version ...rather have the Tesla 3 now....Oy
Kiwi

https://finance.yahoo.com/news/proteon-therapeutics-announces-publication-results-130000873.html